Cite
HARVARD Citation
Buonerba, C. et al. (2013). Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer. Future oncology. pp. 889-897. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Buonerba, C. et al. (2013). Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer. Future oncology. pp. 889-897. [Online].